Health insurers, Medicaid, and state employee health plans would cover medically necessary tests and approved treatments for people with Alzheimer’s disease or related disorders.
Health insurers, Medicaid, and state employee health plans would cover medically necessary tests and FDA-approved treatments to slow Alzheimer’s disease and related disorders, without requiring people to try another treatment first.
Health insurers and specified state health plans would cover medically necessary tests and certain approved treatments. The requirement covers health insurance carriers, the State Medicaid Program, and the State and School Employees’ Health Benefits Programs for Alzheimer’s disease and related disorders. A physician must determine that the care is medically necessary and that treatment follows the FDA label. Coverage for treatments or medicines would not require a person to try another treatment first.
No hearings or votes scheduled.